fbpx

< Back to Thought Leadership

Pharmacy Consulting Group: Expanding Blue’s Services

Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of multiple pharmacy staff members in 2020, Blue is positioned to provide a wide array of pharmacy consulting services to healthcare organizations looking for guidance.

About Blue’s Pharmacy Consulting Group

The Pharmacy Consulting Group is a multi-disciplinary team of pharmacy professionals capable of assisting clients with services such as hospital pharmacy operations and finance, pharmacy benefits consulting, retail and specialty pharmacy analysis and implementation assistance, expertise in provider based hospital consulting and expanded 340B assistance.

In order to provide high quality pharmacy consulting for its clients, Blue has added three additional pharmacy subject matter experts with the following specialties:

  • Retail and specialty pharmacy consulting
  • Hospital pharmacy operations and 340B compliance
  • Pharmacy benefits consulting and support

Blue’s healthcare consulting practice continues to be a leader in providing financial auditing and consulting services to clients across many states. With the expansion of the pharmacy team, Blue can now provide excellent pharmacy and 340B consulting services to clients with the same level of expertise as it does with all of its financial services.

Please reach out to one of our Pharmacy Consulting Group members for more information about how we can serve you and your organization.

Share this article

cost segregation study

Unlocking Cash Flow: The Strategic Advantage of Cost Segregation

By Caleb Young, CPA, Manager at Blue & Co. The Advantage of Cost Segregation Studies For Real Estate Investment What if you could significantly increase your cash flow in the first year of […]

Learn More
Original 340B Rebate Model Withdrawn, HRSA Seeks Public Input on Future Rebate Models

Original 340B Rebate Model Withdrawn, HRSA Seeks Public Input on Future Rebate Models

After nearly two months of uncertainty and legal challenges to the initial 340B rebate model pilot program, HRSA is now seeking public input on a future pilot program through March […]

Learn More
PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

Congress has again postponed the next PAMA clinical lab reporting period. Hospitals and outreach labs should still prepare. The new guidelines moved the reporting window to May 1, 2026, through […]

Learn More